Lataa...
Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic hyperplasia (BPH). We performed a literature search using PubMed, Medline via Ovid, Embase, and the Cochrane Library databases to identify studies on the treatment of BPH by silodosin...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4199653/ https://ncbi.nlm.nih.gov/pubmed/25328864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S41618 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|